IBDEI0J2 ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,8329,0)
 ;;=C85.18^^65^530^8
 ;;^UTILITY(U,$J,358.3,8329,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8329,1,3,0)
 ;;=3^B-Cell Lymphoma,Unspec,Multiple Site Lymph Nodes
 ;;^UTILITY(U,$J,358.3,8329,1,4,0)
 ;;=4^C85.18
 ;;^UTILITY(U,$J,358.3,8329,2)
 ;;=^5001709
 ;;^UTILITY(U,$J,358.3,8330,0)
 ;;=C85.17^^65^530^9
 ;;^UTILITY(U,$J,358.3,8330,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8330,1,3,0)
 ;;=3^B-Cell Lymphoma,Unspec,Spleen
 ;;^UTILITY(U,$J,358.3,8330,1,4,0)
 ;;=4^C85.17
 ;;^UTILITY(U,$J,358.3,8330,2)
 ;;=^5001708
 ;;^UTILITY(U,$J,358.3,8331,0)
 ;;=C85.10^^65^530^10
 ;;^UTILITY(U,$J,358.3,8331,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8331,1,3,0)
 ;;=3^B-Cell Lymphoma,Unspec,Unspec Site
 ;;^UTILITY(U,$J,358.3,8331,1,4,0)
 ;;=4^C85.10
 ;;^UTILITY(U,$J,358.3,8331,2)
 ;;=^5001701
 ;;^UTILITY(U,$J,358.3,8332,0)
 ;;=L60.1^^65^531^2
 ;;^UTILITY(U,$J,358.3,8332,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8332,1,3,0)
 ;;=3^Onycholysis
 ;;^UTILITY(U,$J,358.3,8332,1,4,0)
 ;;=4^L60.1
 ;;^UTILITY(U,$J,358.3,8332,2)
 ;;=^186837
 ;;^UTILITY(U,$J,358.3,8333,0)
 ;;=L60.2^^65^531^1
 ;;^UTILITY(U,$J,358.3,8333,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8333,1,3,0)
 ;;=3^Onychogryphosis
 ;;^UTILITY(U,$J,358.3,8333,1,4,0)
 ;;=4^L60.2
 ;;^UTILITY(U,$J,358.3,8333,2)
 ;;=^5009235
 ;;^UTILITY(U,$J,358.3,8334,0)
 ;;=B35.1^^65^531^3
 ;;^UTILITY(U,$J,358.3,8334,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8334,1,3,0)
 ;;=3^Onychomycosis
 ;;^UTILITY(U,$J,358.3,8334,1,4,0)
 ;;=4^B35.1
 ;;^UTILITY(U,$J,358.3,8334,2)
 ;;=^119748
 ;;^UTILITY(U,$J,358.3,8335,0)
 ;;=L60.3^^65^531^4
 ;;^UTILITY(U,$J,358.3,8335,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8335,1,3,0)
 ;;=3^Onychorrexis/Onychodystrophy
 ;;^UTILITY(U,$J,358.3,8335,1,4,0)
 ;;=4^L60.3
 ;;^UTILITY(U,$J,358.3,8335,2)
 ;;=^5009236
 ;;^UTILITY(U,$J,358.3,8336,0)
 ;;=L50.8^^65^532^4
 ;;^UTILITY(U,$J,358.3,8336,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8336,1,3,0)
 ;;=3^Urticaria,Other Spec
 ;;^UTILITY(U,$J,358.3,8336,1,4,0)
 ;;=4^L50.8
 ;;^UTILITY(U,$J,358.3,8336,2)
 ;;=^5009203
 ;;^UTILITY(U,$J,358.3,8337,0)
 ;;=L50.0^^65^532^2
 ;;^UTILITY(U,$J,358.3,8337,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8337,1,3,0)
 ;;=3^Urticaria,Allergic
 ;;^UTILITY(U,$J,358.3,8337,1,4,0)
 ;;=4^L50.0
 ;;^UTILITY(U,$J,358.3,8337,2)
 ;;=^5009200
 ;;^UTILITY(U,$J,358.3,8338,0)
 ;;=L50.6^^65^532^3
 ;;^UTILITY(U,$J,358.3,8338,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8338,1,3,0)
 ;;=3^Urticaria,Contact
 ;;^UTILITY(U,$J,358.3,8338,1,4,0)
 ;;=4^L50.6
 ;;^UTILITY(U,$J,358.3,8338,2)
 ;;=^5009202
 ;;^UTILITY(U,$J,358.3,8339,0)
 ;;=L50.2^^65^532^1
 ;;^UTILITY(U,$J,358.3,8339,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8339,1,3,0)
 ;;=3^Urticaria d/t Cold/Heat
 ;;^UTILITY(U,$J,358.3,8339,1,4,0)
 ;;=4^L50.2
 ;;^UTILITY(U,$J,358.3,8339,2)
 ;;=^271938
 ;;^UTILITY(U,$J,358.3,8340,0)
 ;;=L56.3^^65^532^5
 ;;^UTILITY(U,$J,358.3,8340,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8340,1,3,0)
 ;;=3^Urticaria,Solar
 ;;^UTILITY(U,$J,358.3,8340,1,4,0)
 ;;=4^L56.3
 ;;^UTILITY(U,$J,358.3,8340,2)
 ;;=^5009217
 ;;^UTILITY(U,$J,358.3,8341,0)
 ;;=B02.8^^65^533^1
 ;;^UTILITY(U,$J,358.3,8341,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8341,1,3,0)
 ;;=3^Zoster w/ Other Complications
 ;;^UTILITY(U,$J,358.3,8341,1,4,0)
 ;;=4^B02.8
 ;;^UTILITY(U,$J,358.3,8341,2)
 ;;=^5000500
